Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Reversing Autism in Mice: Autism comprises a heterogeneous group of neurodevelopmental disorders characterized by defects in communication and social inter action. A group of nonsyndromic forms of autism is associated with mutations in the neuroligin genes, which encode postsynaptic adhesion molecules. Using a reversible knockout approach, Baudouin et al. (p. 128 , published online 13 September) investigated the in vivo functions of neuroligin-3 in the mouse cerebellum. Mutant mice showed a major defect in metabotropic glutamate receptor–dependent, long-term potentiation; disrupted heterosynaptic competition; and ectopic synapse formation in vivo. These synaptic defects could be rescued by reactivation of the neuroligin gene in the adult.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nlgn3 knockout mice show ectopic synapse formation and perturbed mGluR-dependent synaptic plasticity, a hallmark of fragile X syndrome. These phenotypes could be rescued by reexpression of Nlgn3 in juvenile mice, again highlighting the possibility of reverting neuronal circuit alterations in autism after the completion of development 71 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [71]
Citations
Cites
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012) · Nature · doi:10.1038/nature11310 · Cited by 888
Neuroligins Determine Synapse Maturation and Function
Varoqueaux, F., Aramuni, G., Rawson, R. L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Südhof, T. C., & Brose, N. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.003 · Cited by 829
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
The neuropsychiatry of the cerebellum — insights from the clinic
Schmahmann, J. D., Weilburg, J. B., & Sherman, J. C. (2007) · The Cerebellum · doi:10.1080/14734220701490995 · Cited by 718
Control of Excitatory and Inhibitory Synapse Formation by Neuroligins
Chih, B., Engelman, H., & Scheiffele, P. (2005) · Science · doi:10.1126/science.1107470 · Cited by 715
Self-citationRare de novo and transmitted copy-number variation in autistic spectrum disorders
Levy, D., Ronemus, M., Yamrom, B., Lee, Y.-H., Leotta, A., Kendall, J., Marks, S., Lakshmi, B., Pai, D., Ye, K., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.015 · Cited by 712
Cited by
From the genetic architecture to synaptic plasticity in autism spectrum disorder
Bourgeron, T. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3992 · Cited by 975
The Cerebellum, Sensitive Periods, and Autism
Wang, S. S.-H., Kloth, A. D., & Badura, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.016 · Cited by 838
Advancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827
Rothwell, P. E., Fuccillo, M. V., Maxeiner, S., Hayton, S. J., Gokce, O., Lim, B. K., Fowler, S. C., Malenka, R. C., & Südhof, T. C. (2014) · Cell · doi:10.1016/j.cell.2014.04.045 · Cited by 477
“We failed to detect any change in either excitatory or inhibitory synaptic function in D2-MSNs, including normal mGluR-LTD at excitatory synapses – a form of synaptic plasticity altered in cerebellar Purkinje cells of NL3-KO mice (Baudouin et al., 2012).”
InfluentialExcitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders
Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468
The Genetic Landscapes of Autism Spectrum Disorders
Huguet, G., Ey, E., & Bourgeron, T. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153431 · Cited by 450
Gephyrin: a master regulator of neuronal function?
Tyagarajan, S. K., & Fritschy, J.-M. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3670 · Cited by 425
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386
Autism spectrum heterogeneity: fact or artifact?
Mottron, L., & Bzdok, D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0748-y · Cited by 332
Emerging connections between cerebellar development, behaviour and complex brain disorders
Sathyanesan, A., Zhou, J., Scafidi, J., Heck, D. H., Sillitoe, R. V., & Gallo, V. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0152-2 · Cited by 321
Horder, J., Petrinovic, M. M., Mendez, M. A., Bruns, A., Takumi, T., Spooren, W., Barker, G. J., Künnecke, B., & Murphy, D. G. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0155-1 · Cited by 309
Self-citationGenes, circuits, and precision therapies for autism and related neurodevelopmental disorders
Sahin, M., & Sur, M. (2015) · Science · doi:10.1126/science.aab3897 · Cited by 295
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
Földy, C., Malenka, R. C., & Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.036 · Cited by 287
Lessons learned from studying syndromic autism spectrum disorders
Sztainberg, Y., & Zoghbi, H. Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4420 · Cited by 281
Autism Spectrum Disorder and the Cerebellum
Becker, E. B. E., & Stoodley, C. J. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00001-0 · Cited by 274
Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K. J., Wolfer, D. P., Welzl, H., Gall, D., Schiffmann, S. N., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.19 · Cited by 258
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Jiang, C.-C., Lin, L.-S., Long, S., Ke, X.-Y., Fukunaga, K., Lu, Y.-M., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 258
Persico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 238
Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice
Peter, S., ten Brinke, M. M., Stedehouder, J., Reinelt, C. M., Wu, B., Zhou, H., Zhou, K., Boele, H.-J., Kushner, S. A., Lee, M. G., et al. (2016) · Nature Communications · doi:10.1038/ncomms12627 · Cited by 224
Self-citationProgress toward treatments for synaptic defects in autism
Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 206
NMDA receptor dysfunction in autism spectrum disorders
Lee, E.-J., Choi, S. Y., & Kim, E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.007 · Cited by 192
“One way to address this question is to carefully monitor the changes occurring along the developmental time axis and, if possible, attempt conditional gene ablation or pharmacological rescue over specific developmental time windows, as previously reported [50,51 ].”
Prediction signals in the cerebellum: Beyond supervised motor learning
Hull, C. (2020) · eLife · doi:10.7554/elife.54073 · Cited by 187
Budreck, E. C., Kwon, O.-B., Jung, J. H., Baudouin, S., Thommen, A., Kim, H.-S., Fukazawa, Y., Harada, H., Tabuchi, K., Shigemoto, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214718110 · Cited by 183
Self-citationBehavioral phenotypes of genetic mouse models of autism
Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12256 · Cited by 178
Bariselli, S., Hörnberg, H., Prévost-Solié, C., Musardo, S., Hatstatt-Burklé, L., Scheiffele, P., & Bellone, C. (2018) · Nature Communications · doi:10.1038/s41467-018-05382-3 · Cited by 171
Self-citationTranslational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5003 · Cited by 170
Genetics of glutamate and its receptors in autism spectrum disorder
Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 170
Witter, L., Rudolph, S., Pressler, R. T., Lahlaf, S. I., & Regehr, W. G. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.037 · Cited by 169
Pischedda, F., Szczurkowska, J., Cirnaru, M. D., Giesert, F., Vezzoli, E., Ueffing, M., Sala, C., Francolini, M., Hauck, S. M., Cancedda, L., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031716 · Cited by 165
Cerebellar plasticity and motor learning deficits in a copy-number variation mouse model of autism
Piochon, C., Kloth, A. D., Grasselli, G., Titley, H. K., Nakayama, H., Hashimoto, K., Wan, V., Simmons, D. H., Eissa, T., Nakatani, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6586 · Cited by 162
Autistic-Like Traits and Cerebellar Dysfunction in Purkinje Cell PTEN Knock-Out Mice
Cupolillo, D., Hoxha, E., Faralli, A., De Luca, A., Rossi, F., Tempia, F., & Carulli, D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.339 · Cited by 162
Biesemann, C., Grønborg, M., Luquet, E., Wichert, S. P., Bernard, V., Bungers, S. R., Cooper, B., Varoqueaux, F., Li, L., Byrne, J. A., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386120 · Cited by 156
“NL3 seems to be present at both types of synapses in the cerebellum (Baudouin et al, 2012), and our findings indicate that NL3 is largely absent from forebrain glutamatergic synapses in vivo.”
BackgroundRescue of oxytocin response and social behaviour in a mouse model of autism
Hörnberg, H., Pérez-Garci, E., Schreiner, D., Hatstatt-Burklé, L., Magara, F., Baudouin, S., Matter, A., Nacro, K., Pecho-Vrieseling, E., & Scheiffele, P. (2020) · Nature · doi:10.1038/s41586-020-2563-7 · Cited by 154
Self-citationZhang, B., Chen, L. Y., Liu, X., Maxeiner, S., Lee, S.-J., Gokce, O., & Südhof, T. C. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.020 · Cited by 154
Enhanced synapse remodelling as a common phenotype in mouse models of autism
Isshiki, M., Tanaka, S., Kuriu, T., Tabuchi, K., Takumi, T., & Okabe, S. (2014) · Nature Communications · doi:10.1038/ncomms5742 · Cited by 152
Cerebellar associative sensory learning defects in five mouse autism models
Kloth, A. D., Badura, A., Li, A., Cherskov, A., Connolly, S. G., Giovannucci, A., Bangash, M. A., Grasselli, G., Peñagarikano, O., Piochon, C., et al. (2015) · eLife · doi:10.7554/elife.06085 · Cited by 145
Ey, E., Torquet, N., Le Sourd, A.-M., Leblond, C. S., Boeckers, T. M., Faure, P., & Bourgeron, T. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.031 · Cited by 140
Genetic aspects of autism spectrum disorders: insights from animal models
Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 139
Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research
Rogers, T. D., McKimm, E., Dickson, P. E., Goldowitz, D., Blaha, C. D., & Mittleman, G. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00015 · Cited by 139
Male and Female Mice Lacking Neuroligin-3 Modify the Behavior of Their Wild-Type Littermates
Kalbassi, S., Bachmann, S. O., Cross, E., Roberton, V. H., & Baudouin, S. J. (2017) · eneuro · doi:10.1523/eneuro.0145-17.2017 · Cited by 137
Self-citationCerebellar control of gait and interlimb coordination
Veloz, M. F. V., Zhou, K., Bosman, L. W. J., Potters, J.-W., Negrello, M., Seepers, R. M., Strydis, C., Koekkoek, S. K. E., & Zeeuw, C. I. D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0870-1 · Cited by 135
Self-citationKas, M. J., Glennon, J. C., Buitelaar, J., Ey, E., Biemans, B., Crawley, J., Ring, R. H., Lajonchere, C., Esclassan, F., Talpos, J., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3268-5 · Cited by 132
STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study
Erickson, C. A., Veenstra-Vanderweele, J. M., Melmed, R. D., McCracken, J. T., Ginsberg, L. D., Sikich, L., Scahill, L., Cherubini, M., Zarevics, P., Walton-Bowen, K., et al. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1963-z · Cited by 125
Regulation of neuronal migration, an emerging topic in autism spectrum disorders
Reiner, O., Karzbrun, E., Kshirsagar, A., & Kaibuchi, K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13403 · Cited by 124
The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models
Mapelli, L., Soda, T., D'Angelo, E. U., & Prestori, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073894 · Cited by 123
Ha, S., Lee, D., Cho, Y. S., Chung, C., Yoo, Y.-E., Kim, J., Lee, J., Kim, W., Kim, H., Bae, Y. C., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1849-16.2016 · Cited by 120
Self-citationNeuroimaging in autism—from basic science to translational research
Ecker, C., & Murphy, D. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.276 · Cited by 113
Use of Transcranial Magnetic Stimulation in Autism Spectrum Disorders
Oberman, L. M., Rotenberg, A., & Pascual‐Leone, Á. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1960-2 · Cited by 113
The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders
Mosconi, M. W., Wang, Z., Schmitt, L. M., Tsai, P., & Sweeney, J. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00296 · Cited by 112
“However, most studies thus far have been limited to describing evidence of cerebellar dysfunction in global models of ASD (Zingerevich et al., 2009; Baudouin et al., 2012; Roullet et al., 2013; Brielmaier et al., 2014; Ellegood et al., 2014; Piochon et al., 2014; Steadman et al., 2014).”
BackgroundCerebellar involvement in autism and ADHD
Bruchhage, M. M. K., Bucci, M. P., & Becker, E. B. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64189-2.00004-4 · Cited by 110
LTD-like molecular pathways in developmental synaptic pruning
Piochon, C., Kano, M., & Hansel, C. (2016) · Nature Neuroscience · doi:10.1038/nn.4389 · Cited by 110
NMDA RECEPTOR DYSFUNCTION IN AUTISM SPECTRUM DISORDERS
Kim, E. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.08.2041 · Cited by 109
A Matter of Balance: Role of Neurexin and Neuroligin at the Synapse
Bang, M., & Owczarek, S. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1029-9 · Cited by 108
The Neurodevelopment of Autism from Infancy Through Toddlerhood
Girault, J. B., & Piven, J. (2019) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2019.09.009 · Cited by 107
Uchigashima, M., Cheung, A., & Futai, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.749164 · Cited by 101
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.003 · Cited by 96
Genomics in neurodevelopmental disorders: an avenue to personalized medicine
Tărlungeanu, D. C., & Novarino, G. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0129-7 · Cited by 96
Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism
Mottron, L., Duret, P., Mueller, S., Moore, R. D., Forgeot d’Arc, B., Jacquemont, S., & Xiong, L. (2015) · Molecular Autism · doi:10.1186/s13229-015-0024-1 · Cited by 94
From mice to men: lessons from mutant ataxic mice
Cendelín, J. (2014) · Cerebellum & Ataxias · doi:10.1186/2053-8871-1-4 · Cited by 94
The neuroligins and the synaptic pathway in Autism Spectrum Disorder
Trobiani, L., Meringolo, M., Diamanti, T., Bourne, Y., Marchot, P., Martella, G., Dini, L., Pisani, A., Jaco, A. D., & Bonsi, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.017 · Cited by 93
Control of neural circuit formation by leucine-rich repeat proteins
de Wit, J., & Ghosh, A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.004 · Cited by 93
The Sorting Receptor SorCS1 Regulates Trafficking of Neurexin and AMPA Receptors
Savas, J. N., Ribeiro, L. F., Wierda, K. D., Wright, R., DeNardo-Wilke, L. A., Rice, H. C., Chamma, I., Wang, Y.-Z., Zemla, R., Lavallée-Adam, M., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.007 · Cited by 92
Autism Spectrum Disorders: Translating human deficits into mouse behavior
Pasciuto, E., Borrie, S. C., Kanellopoulos, A. K., Santos, A. R., Cappuyns, E., D’Andrea, L., Pacini, L., & Bagni, C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.013 · Cited by 91
Haberl, M. G., Zerbi, V., Veltien, A., Ginger, M., Heerschap, A., & Frick, A. (2015) · Science Advances · doi:10.1126/sciadv.1500775 · Cited by 90
Liu, A., Zhou, Z., Dang, R., Zhu, Y., Qi, J., He, G., Leung, C., Pak, D., Jia, Z., & Xie, W. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201509023 · Cited by 87
Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and Challenges
Loth, E., Murphy, D. G., & Spooren, W. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00188 · Cited by 86
Self-citationDeregulation of synaptic plasticity in autism
Hansel, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.003 · Cited by 85
Brito-Moreira, J., Lourenco, M. V., Oliveira, M. M., Ribeiro, F. C., Ledo, J. H., Diniz, L. P., Vital, J. F. S., Magdesian, M. H., Melo, H. M., Barros-Aragão, F., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761189 · Cited by 84
“Mutations in NL3 have further been shown to result in cognitive and behavioral deficits in autism models (21).”
BackgroundDas, U. N. (2013) · Nutrition · doi:10.1016/j.nut.2013.01.012 · Cited by 83
Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
Telias, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00051 · Cited by 82
Synapse Assembly and Neurodevelopmental Disorders
Washbourne, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.163 · Cited by 80
Autism spectrum disorder: prospects for treatment using gene therapy
Benger, M., Kinali, M., & Mazarakis, N. D. (2018) · Molecular Autism · doi:10.1186/s13229-018-0222-8 · Cited by 80
Stoodley, C. J., & Tsai, P. T. (2021) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100120-092143 · Cited by 79
Uzunova, G., Hollander, E., & Shepherd, J. D. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660046 · Cited by 78
McDiarmid, T. A., Belmadani, M., Liang, J., Meili, F., Mathews, E., Mullen, G. P., Hendi, A., Wong, W.-R., Rand, J. B., Mizumoto, K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912049116 · Cited by 78
Behavioral signatures related to genetic disorders in autism
Bruining, H., Eijkemans, M. J., Kas, M. J., Curran, S. R., Vorstman, J. A., & Bolton, P. F. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-11 · Cited by 77
“Indeed, the notion that pathophysiological processes are shared in syndromic and idiopathic cases of ASD is supported by a recent study that showed converging synaptic pathophysiology between syndromic (for example as a cause of a defined genetic disorder) and non-syndromic rodent models of autism [50].”
BackgroundNeurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeisser, M. J., Krueger, D. D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 75
Self-citationMottron, L., Belleville, S., Rouleau, G. A., & Collignon, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.012 · Cited by 75
EU-AIMS: a boost to autism research
Murphy, D., & Spooren, W. P. J. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3881 · Cited by 72
Self-citationSteinberg, J., & Webber, C. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.013 · Cited by 71
“Indeed, it has been shown recently that some symptoms in a mouse model of ASD can be rescued at a juvenile stage.(53) The evidence that we found for a multiple-hit etiology in ASD is consistent with two different mechanisms of disease onset: (1) in an additive model, each disruption of relevant biological processes le…”
BackgroundWaltes, R., Duketis, E., Knapp, M., Anney, R. J. L., Huguet, G., Schlitt, S., Jarczok, T. A., Sachse, M., Kämpfer, L. M., Kleinböck, T., et al. (2014) · Human Genetics · doi:10.1007/s00439-013-1416-y · Cited by 71
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 71
Tu, Y.-K., Duman, J. G., & Tolias, K. F. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3461-17.2018 · Cited by 66
Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders
Cao, X., & Tabuchi, K. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.09.005 · Cited by 65
Domanski, A. P. F., Booker, S. A., Wyllie, D. J. A., Isaac, J. T. R., & Kind, P. C. (2019) · Nature Communications · doi:10.1038/s41467-019-12736-y · Cited by 65
Syndromic Autism Revisited: Review of the Literature and Lessons Learned
Ziats, C. A., Patterson, W. G., & Friez, M. J. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.06.011 · Cited by 64
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
Aavani, T., Rana, S. A., Hawkes, R. B., & Pittman, Q. J. (2015) · The Cerebellum · doi:10.1007/s12311-015-0669-5 · Cited by 60
Modi, B., Pimpinella, D., Pazienti, A., Zacchi, P., Cherubini, E., & Griguoli, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00513 · Cited by 60
Microglia: Synaptic modulator in autism spectrum disorder
Hu, C., Li, H., Li, J., Luo, X., & Hao, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.958661 · Cited by 60
Guo, W., Molinaro, G., Collins, K. A., Hays, S. A., Paylor, R. E., Worley, P. F., Szumlinski, K. K., & Huber, K. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2921-15.2016 · Cited by 59
ASTN2 modulates synaptic strength by trafficking and degradation of surface proteins
Behesti, H., Fore, T. R., Wu, P., Horn, Z., Leppert, M., Hull, C., & Hatten, M. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809382115 · Cited by 59
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 56
Díaz-Caneja, C., State, M., Hagerman, R., Jacquemont, S., Marín, O., Bagni, C., Umbricht, D., Simonoff, E., de Andrés-Trelles, F., Kaale, A., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.020 · Cited by 55
Pumping the brakes: suppression of synapse development by MDGA–neuroligin interactions
Connor, S. A., Elegheert, J., Xie, Y., & Craig, A. M. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.01.002 · Cited by 55
Cocks, G. D., Curran, S. R., Gami‐Patel, P., Uwanogho, D., Jeffries, A. R., Kathuria, A., Lucchesi, W., Wood, V. H. J., Dixon, R., Ogilvie, C. M., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3196-4 · Cited by 52
Poulin-Lord, M.-P., Barbeau, É. B., Soulières, I., Monchi, O., Doyon, J., Benali, H., & Mottron, L. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.02.008 · Cited by 52
Kelly, E., Escamilla, C. O., & Tsai, P. T. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.012 · Cited by 50
Targeting epigenetic dysregulation in autism spectrum disorders
Herrera, M. L., Paraíso‐Luna, J., Bustos-Martínez, I., & Barco, Á. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.06.004 · Cited by 50
Metadata
- Authors
- Baudouin, S. J., Gaudias, J., Gerharz, S., Hatstatt, L., Zhou, K., Punnakkal, P., Tanaka, K. F., Spooren, W., Hen, R., De Zeeuw, C. I., Vogt, K., & Scheiffele, P.
- Affiliations
- University of Basel (CH)
- Biozentrum of the University of Basel, Basel, Switzerland.
- Erasmus MC (NL)
- Keio University (JP)
- F. Hoffmann-La Roche AG (CH)
- Department of Neuroscience, Columbia University, New York, NY, USA.
- Department of Neuroscience, Erasmus MC, Rotterdam, Netherlands.
- Corresponding author
- Scheiffele, Peter
- ORCID
- Venue
- Science
- Published
- 2012-10-05
- Volume
- 338
- Issue
- 6103
- Pages
- 128-132
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2122905516
- Cited by
- 293
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 15 · 2023: 6 · 2022: 19 · 2021: 20 · 2020: 22 · 2019: 26 · 2018: 15 · 2017: 22 · 2016: 25 · 2015: 24 · 2014: 46 · 2013: 35 · 2012: 4
- FWCI
- 20.67
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Funders
- Erasmus+
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- autism spectrum disorder, synaptic plasticity, neuroligin-3, fragile X syndrome, metabotropic glutamate receptors, rare mutations, genetic heterogeneity
- MeSH terms
- Animals, Autistic Disorder, Disease Models, Animal, Fragile X Syndrome, Male, Membrane Proteins, Mice, Inbred C57BL, Nerve Net, Nerve Tissue Proteins, Neuronal Plasticity, Synapses, Cell Adhesion Molecules, Neuronal, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.